{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:26:05Z","timestamp":1792599965869,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1910834"],"award-info":[{"award-number":["W81XWH1910834"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006438","name":"Office of the Assistant Secretary for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013786","name":"Cure EB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omta.2026.201737","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:26:25Z","timestamp":1776295585000},"page":"201737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa"],"prefix":"10.1016","volume":"34","author":[{"given":"Christine","family":"Gretzmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Sengle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Buer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arseniy","family":"Belov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Bleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Brinckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal","family":"Landy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-2240","authenticated-orcid":false,"given":"Alexander","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201737_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","article-title":"Epidermolysis bullosa","volume":"6","author":"Bardhan","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omta.2026.201737_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.matbio.2025.02.001","article-title":"Dystrophic Epidermolysis Bullosa - from biochemistry to interventions","volume":"136","author":"Nystr\u00f6m","year":"2025","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omta.2026.201737_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaad.2019.11.038","article-title":"Phase I\/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa","volume":"83","author":"Rashidghamat","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102900","article-title":"Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1\/2 trial","volume":"77","author":"Kiritsi","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.omta.2026.201737_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bjd\/ljac001","article-title":"Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study","volume":"188","author":"Kern","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib6","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","article-title":"Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa","volume":"387","author":"Guide","year":"2022","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omta.2026.201737_bib7","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.omta.2026.201737_bib8","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jid.2023.05.024","article-title":"Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa","volume":"143","author":"South","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/bjd\/ljae300","article-title":"Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa","volume":"191","author":"South","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2018.12.001","article-title":"Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa","volume":"81","author":"Cianfarani","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omta.2026.201737_bib11","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1093\/hmg\/ddu102","article-title":"Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-\u03b2 signalling in modifying disease severity","volume":"23","author":"Odorisio","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201737_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","article-title":"Proteoglycan form and function: A comprehensive nomenclature of proteoglycans","volume":"42","author":"Iozzo","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omta.2026.201737_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1083\/jcb.136.3.729","article-title":"Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility","volume":"136","author":"Danielson","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omta.2026.201737_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1167\/iovs.04-0804","article-title":"Congenital Stromal Dystrophy of the Cornea Caused by a Mutation in the Decorin Gene","volume":"46","author":"Bredrup","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201737_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.matbio.2016.09.009","article-title":"Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions","volume":"55","author":"Gubbiotti","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omta.2026.201737_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ajpath.2012.04.029","article-title":"Decorin: a guardian from the matrix","volume":"181","author":"Neill","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omta.2026.201737_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/360361a0","article-title":"Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease","volume":"360","author":"Border","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201737_bib18","doi-asserted-by":"crossref","first-page":"C554","DOI":"10.1152\/ajpcell.00016.2022","article-title":"Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways","volume":"322","author":"Xie","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omta.2026.201737_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/nano10020226","article-title":"Systemically Administered, Target-Specific, Multi-Functional Therapeutic Recombinant Proteins in Regenerative Medicine","volume":"10","author":"J\u00e4rvinen","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.omta.2026.201737_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","article-title":"Negative regulation of transforming growth factor-beta by the proteoglycan decorin","volume":"346","author":"Yamaguchi","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201737_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0002-9440(10)64937-1","article-title":"Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction","volume":"160","author":"Schaefer","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omta.2026.201737_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0002-9440(10)63305-6","article-title":"Regulation of Fibrillin-1 by Biglycan and Decorin Is Important for Tissue Preservation in the Kidney During Pressure-Induced Injury","volume":"165","author":"Schaefer","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omta.2026.201737_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021907","article-title":"Regulation of the Bioavailability of TGF-\u03b2 and TGF-\u03b2-Related Proteins","volume":"8","author":"Robertson","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omta.2026.201737_bib24","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ymthe.2020.05.017","article-title":"Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa","volume":"28","author":"Pemmari","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201737_bib25","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/srep02422","article-title":"Age-dependent alterations of decorin glycosaminoglycans in human skin","volume":"3","author":"Li","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201737_bib26","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1111\/j.1742-4658.2007.05951.x","article-title":"The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis","volume":"274","author":"Claus","year":"2007","journal-title":"The FEBS Journal"},{"key":"10.1016\/j.omta.2026.201737_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/654765","article-title":"Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition","volume":"2015","author":"J\u00e4rvinen","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.omta.2026.201737_bib28","doi-asserted-by":"crossref","first-page":"42774","DOI":"10.1074\/jbc.M511531200","article-title":"Decorin core protein secretion is regulated by N-linked oligosaccharide and glycosaminoglycan additions","volume":"280","author":"Seo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib29","doi-asserted-by":"crossref","first-page":"19578","DOI":"10.1074\/jbc.271.32.19578","article-title":"Recombinant decorin glycoforms. Purification and structure","volume":"271","author":"Ramamurthy","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib30","series-title":"Decorin Compositions and Use Thereof","author":"Bleck","year":"2022"},{"key":"10.1016\/j.omta.2026.201737_bib31","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jid.2021.09.008","article-title":"Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa","volume":"142","author":"Gretzmeier","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib32","doi-asserted-by":"crossref","first-page":"42075","DOI":"10.1074\/jbc.M110.172841","article-title":"Decorin Antagonizes Met Receptor Activity and Down-regulates \u03b2-Catenin and Myc Levels","volume":"285","author":"Buraschi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114392","article-title":"Pro-inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang-(1-7)","volume":"13","author":"Bernasconi","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omta.2026.201737_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3928\/1081597X-20160428-08","article-title":"Ex Vivo Transepithelial Collagen Cross-linking in Porcine and Human Corneas Using Human Decorin Core Protein","volume":"32","author":"Metzler","year":"2016","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.omta.2026.201737_bib35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0021-9258(17)35235-3","article-title":"Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-alpha-inhibitor","volume":"266","author":"Enghild","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib36","doi-asserted-by":"crossref","first-page":"15633","DOI":"10.1073\/pnas.0402976101","article-title":"Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan","volume":"101","author":"Scott","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201737_bib37","doi-asserted-by":"crossref","first-page":"35526","DOI":"10.1074\/jbc.M113.504530","article-title":"The concave face of decorin mediates reversible dimerization and collagen binding","volume":"288","author":"Islam","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib38","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1111\/j.1432-1033.2004.04273.x","article-title":"Differential interactions of decorin and decorin mutants with type I and type VI collagens","volume":"271","author":"Nareyeck","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omta.2026.201737_bib39","doi-asserted-by":"crossref","first-page":"C1853","DOI":"10.1152\/ajpcell.01075.2024","article-title":"Decorin the antifibrotic proteoglycan and its progression in therapy","volume":"328","author":"Baghy","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omta.2026.201737_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0304-4165(98)00163-9","article-title":"Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice","volume":"1426","author":"Masuda","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omta.2026.201737_bib41","doi-asserted-by":"crossref","first-page":"21671","DOI":"10.1073\/pnas.1016233107","article-title":"Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice","volume":"107","author":"J\u00e4rvinen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201737_bib42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.omta.2026.201737_bib43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jid.2016.03.036","article-title":"Fibroblast-Derived MMP-14 Regulates Collagen Homeostasis in Adult Skin","volume":"136","author":"Zigrino","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib44","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Nystr\u00f6m","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omta.2026.201737_bib45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/bjd\/ljae225","article-title":"Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa","volume":"191","author":"Primerano","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0925-4439(96)00019-1","article-title":"Lung collagen cross-links in rats with experimentally induced pulmonary fibrosis","volume":"1316","author":"Gerriets","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omta.2026.201737_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbadis.2005.02.007","article-title":"The type of collagen cross-link determines the reversibility of experimental skin fibrosis","volume":"1740","author":"van der Slot-Verhoeven","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omta.2026.201737_bib48","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.jid.2024.03.020","article-title":"Dipeptidyl Peptidase-4-Mediated Fibronectin Processing Evokes a Profibrotic Extracellular Matrix","volume":"144","author":"Zeyer","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib49","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jid.2017.07.002","article-title":"Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration","volume":"137","author":"Alexeev","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib50","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.jid.2025.01.010","article-title":"Knockout of IL-1R1 Reduced Inflammation and Improved Survival in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa","volume":"145","author":"Anderson-Crannage","year":"2025","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001868","article-title":"Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21","volume":"4","author":"Merline","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.omta.2026.201737_bib52","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1369\/0022155420930303","article-title":"Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases","volume":"68","author":"Zeng-Brouwers","year":"2020","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.omta.2026.201737_bib53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200608167","article-title":"Fibrillin-1 regulates the bioavailability of TGF\u03b21","volume":"176","author":"Chaudhry","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omta.2026.201737_bib54","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jid.2020.10.024","article-title":"Diversity of Mechanisms Underlying Latent TGF-\u03b2 Activation in Recessive Dystrophic Epidermolysis Bullosa","volume":"141","author":"Akasaka","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib55","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1074\/jbc.274.8.4489","article-title":"Decorin is a biological ligand for the epidermal growth factor receptor","volume":"274","author":"Iozzo","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib56","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.200901129","article-title":"Decorin is a novel antagonistic ligand of the Met receptor","volume":"185","author":"Goldoni","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omta.2026.201737_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2317760121","article-title":"Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression","volume":"121","author":"Mondal","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201737_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cyto.2018.12.010","article-title":"Synergetic roles of TGF-\u03b2 signaling in tissue engineering","volume":"115","author":"Kwak","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.omta.2026.201737_bib59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/abbi.1998.0720","article-title":"Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen","volume":"355","author":"Sch\u00f6nherr","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.omta.2026.201737_bib60","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1091\/mbc.12.9.2730","article-title":"Alpha-smooth muscle actin expression upregulates fibroblast contractile activity","volume":"12","author":"Hinz","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.omta.2026.201737_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","article-title":"The extracellular matrix and transforming growth factor-\u03b21: Tale of a strained relationship","volume":"47","author":"Hinz","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omta.2026.201737_bib62","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbamcr.2008.12.012","article-title":"The regulation of tenascin expression by tissue microenvironments","volume":"1793","author":"Tucker","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omta.2026.201737_bib63","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/S0021-9258(17)35666-1","article-title":"Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix","volume":"261","author":"Ignotz","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40257-025-00942-y","article-title":"Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa","volume":"26","author":"Marinkovich","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.omta.2026.201737_bib65","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3390\/cells9122646","article-title":"Glycosaminoglycan Modification of Decorin Depends on MMP14 Activity and Regulates Collagen Assembly","volume":"9","author":"Daquinag","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201737_bib66","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/cvr\/cvaf128","article-title":"Ageing-associated endothelial decorin induction and the impact of non-glycanated decorin on cardiac inflammation","volume":"121","author":"Lux\u00e1n","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omta.2026.201737_bib67","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s13402-024-00998-8","article-title":"Non-glycanated \u0394DCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance","volume":"47","author":"Wu","year":"2024","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.omta.2026.201737_bib68","doi-asserted-by":"crossref","first-page":"26408","DOI":"10.1074\/jbc.M602853200","article-title":"Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation","volume":"281","author":"Seidler","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201737_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045559","article-title":"Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model","volume":"7","author":"Buraschi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201737_bib70","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1460-9568.2004.03184.x","article-title":"Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries","volume":"19","author":"Davies","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.omta.2026.201737_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12952-017-0074-3","article-title":"Absence of the dermatan sulfate chain of decorin does not affect mouse development","volume":"16","author":"Moffatt","year":"2017","journal-title":"J. Negat. Results Biomed."},{"key":"10.1016\/j.omta.2026.201737_bib72","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","article-title":"Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression","volume":"76","author":"Mittapalli","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.omta.2026.201737_bib73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.matbio.2005.07.002","article-title":"Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?","volume":"24","author":"Brinckmann","year":"2005","journal-title":"Matrix Biol."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:31:43Z","timestamp":1788553903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3117387X26000728"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201737","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201737"}}